Meet our Team
Leadership
Michael Weiner
CEO & Founder
Dr. Weiner is a serial scientific entrepreneur and the Founder of Abbratech Inc.
Board of Directors
Michael Weiner
Dr. Weiner is a serial scientific entrepreneur and the Founder of Abbratech Inc.
Michael Egholm, Ph.D.
Dr. Egholm brings more than 27 years of proven leadership in developing and commercializing innovative technologies.
Sean Mackay
Sean Mackay co-founded and leads IsoPlexis as CEO. IsoPlexis’ mission is to provide widely accessible cellular proteomics to speed personalized, curative medicines.
Sean Cassidy
Mr. Cassidy is the Chief Financial Officer of Arvinas with over 20 years of experience in the life sciences industry
Kenan Turnacioglu, Ph.D.
Dr. Turnacioglu is currently Chairperson of PaigeAI, a machine learning Pathology company spun out of Memorial Sloan Kettering
Medical Advisory Board
John Hastewell, DPhil
John Hastewell served in many roles in his nearly 30 years at Novartis.
Robert Hollingsworth, Ph.D.
Dr. Hollingsworth is the Chief Scientific Officer at Shoreline Biosciences.
Rachel Humphrey, M.D
Dr. Humphrey is the President and CEO of an Immuno-oncology start-up.
Ulf Landegren, M.D., Ph.D
Ulf Landegren received his MD and PhD in Uppsala, Sweden, before spending five years at California Institute of Technology
Technical Advisory Board
Michael P. Snyder, Ph.D.
Michael Snyder is the Stanford Ascherman Professor, Chair of Genetics, and Director of the Center of Genomics and Personalized Medicine.
Dieter Söll, Ph.D.
Dieter Gerhard Söll is a Sterling Professor of Molecular Biophysics and Biochemistry and Chemistry at the Yale University.
David Weitz, Ph.D.
David A. Weitz is the Mallinckrodt Professor of Physics and Applied Physics at Harvard University.